A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Rochester
AbbVie
Novartis
Takeda
Roswell Park Cancer Institute
Gamida Cell ltd
M.D. Anderson Cancer Center
Brown University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
Novartis
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
National Institutes of Health Clinical Center (CC)
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia Japan K.K.
Novartis
Novartis
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Novo Nordisk A/S
M.D. Anderson Cancer Center
American Regent, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Novartis
M.D. Anderson Cancer Center
Washington University School of Medicine